Crucially, our experiments revealed that knockdown of TAGLN2 in thyroid papillary carcinoma cells led to a significant decrease in p-Smad2 levels, indicating an attenuation of TGF-β signaling activation. This evidence concerns the gene SMAD2 and thyroid gland papillary carcinoma.